Application 017054
- Type
- BLA
- Sponsor
- BEL MAR
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 017054 | Chorionic Gonadotropin | chorionic gonadotropin | 351(a) | Disc | 2026-09-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CHORIONIC GONADOTROPIN | GONADOTROPIN, CHORIONIC | INJECTABLE;INJECTION | 5,000 UNITS/VIAL | No | No |
| 002 | CHORIONIC GONADOTROPIN | GONADOTROPIN, CHORIONIC | INJECTABLE;INJECTION | 10,000 UNITS/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Chorionic Gonadotropin | CHORIONIC GONADOTROPIN | Fresenius Kabi USA, LLC | f93b2baa-03ac-4650-b35a-20b818d712d6 | 2025-04-11 | Warnings, Adverse reactions | Chorionic Gonadotropin |
| Chorionic Gonadotropin | CHORIONIC GONADOTROPIN | NuCare Pharmaceuticals,Inc. | 312ee87a-c6c3-6111-e063-6394a90ad8d7 | 2025-03-25 | Warnings, Adverse reactions | Chorionic Gonadotropin |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 62252 | APPL | 2020-03-23 |